Vaughan CW

References (5)

Title : Actions of the dual FAAH\/MAGL inhibitor JZL195 in a murine neuropathic pain model - Adamson_2016_Br.J.Pharmacol_173_77
Author(s) : Adamson Barnes NS , Mitchell VA , Kazantzis NP , Vaughan CW
Ref : British Journal of Pharmacology , 173 :77 , 2016
Abstract :
PubMedSearch : Adamson_2016_Br.J.Pharmacol_173_77
PubMedID: 26398331

Title : Actions of the dual FAAH\/MAGL inhibitor JZL195 in a murine inflammatory pain model - Anderson_2014_Neuropharmacol_81_224
Author(s) : Anderson WB , Gould MJ , Torres RD , Mitchell VA , Vaughan CW
Ref : Neuropharmacology , 81 :224 , 2014
Abstract :
PubMedSearch : Anderson_2014_Neuropharmacol_81_224
PubMedID: 24384256

Title : Endocannabinoid modulation by FAAH and monoacylglycerol lipase within the analgesic circuitry of the periaqueductal grey - Lau_2014_Br.J.Pharmacol_171_5225
Author(s) : Lau BK , Drew GM , Mitchell VA , Vaughan CW
Ref : British Journal of Pharmacology , 171 :5225 , 2014
Abstract :
PubMedSearch : Lau_2014_Br.J.Pharmacol_171_5225
PubMedID: 25041240

Title : Cholecystokinin exerts an effect via the endocannabinoid system to inhibit GABAergic transmission in midbrain periaqueductal gray - Mitchell_2011_Neuropsychopharmacology_36_1801
Author(s) : Mitchell VA , Jeong HJ , Drew GM , Vaughan CW
Ref : Neuropsychopharmacology , 36 :1801 , 2011
Abstract :
PubMedSearch : Mitchell_2011_Neuropsychopharmacology_36_1801
PubMedID: 21525858

Title : Muscarinic modulation of synaptic transmission via endocannabinoid signalling in the rat midbrain periaqueductal gray - Lau_2008_Mol.Pharmacol_74_1392
Author(s) : Lau BK , Vaughan CW
Ref : Molecular Pharmacology , 74 :1392 , 2008
Abstract :
PubMedSearch : Lau_2008_Mol.Pharmacol_74_1392
PubMedID: 18678620